Clinical significance of micrometastasis of stage II colorectal cancer. A prospective multicenter trial

Authors
Category Primary study
JournalUMIN Clinical Trials Registry
Year 2006
INTERVENTION: Randomization in micrometastasis positive cases HCHU 300mg for 1 year Randomization in micrometastasis positive cases No therapy CONDITION: Stage II colorectal cancer PRIMARY OUTCOME: 3 year‐disease free survival when stratified by presense or absence of micrometastasis SECONDARY OUTCOME: 5 year‐overall survival when stratified by presense or absence of micrometastasis INCLUSION CRITERIA: Curatively resected Stage II colorectal cancer With informed consent,performance status is 0‐2.
Epistemonikos ID: d655c865cc70e5f3b77d707fe127572e6e51a6d6
First added on: Aug 21, 2024